SGLT2 Inhibitors May Prevent Diabetic Kidney Disease SGLT2 Inhibitors May Prevent Diabetic Kidney Disease

Patients with type 2 diabetes in real-world practice who received an SGLT2 inhibitor rather than a DPP-4 inhibitor were less likely to develop serious renal events, consistent with clinical trial findings.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news